Toxoplasma gondii
is capable of being transmitted by nearly all warm-blooded animals, and rodents are a major source of parasite dissemination, yet mechanisms driving its broad host range are poorly understood. Although a phylogenetically close relative of
T. gondii
,
Neospora caninum
differs from
T. gondii
in that it does not infect mice and only infects a small number of ruminant and canine species. We recently showed that
T. gondii
and
N. caninum
grow similarly in mice during the first 24 h post-infection, but only
N. caninum
induces an IFNγ-driven response within hours that controls the infection. The goal of the present study was to understand the cellular basis of this rapid response to
N. caninum
. To do this, we compared immune cell populations at the site of infection 4 h after
T. gondii
or
N. caninum
infection in mice. We found that both parasites induced similar frequencies of peritoneal monocytes, while macrophages and dendritic cell populations were not increased compared to uninfected mice. Through a series of knockout mouse experiments, we show that B, T, and NKT cells are not required for immediate IFNγ production and ultimate control of
N. caninum
infection, suggesting that natural killer (NK) cells are the primary inducers of immediate IFNγ in response to
N. caninum. N. caninum
infections exhibited significantly more IFNγ
+
NK cells in the peritoneum compared with
T. gondii
-infected and uninfected mice. Finally, we demonstrate that differences in early IFNγ production during
N. caninum
and
T. gondii
infections in mice are at least partly due to differences in soluble antigen(s) produced by tachyzoites.
IMPORTANCE
Pathogen differences in host range are poorly understood at the molecular level even though even closely related pathogen species can have dramatically distinct host ranges. Here, we study two related parasite species that have a dramatic difference in their ability to infect mice. Here, we show that soluble proteins from these species determine one driver of this difference: induction of interferon gamma by cells of the innate immune system.